Skip to main content

Table 3 Empiric therapy used in treatment of suspected SAB

From: Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study

Empiric therapy

2011 (Baseline)

2012 (Intervention)

Odds ratio (95 % CI)

P value

Solely Cefazolin or Cloxacillin

14/102 (13.7 %)

3/96 (3.1 %)

0.20 (0.06–0.73)

0.01

Solely Vancomycin

32/102 (31.4 %)

36/96 (37.5 %)

1.31 (0.73–2.36)

0.36

Vancomycin + Cefazolin/Cloxacillin

14/102 (13.7 %)

22/96 (22.9 %)

1.87 (0.89–3.91)

0.09

Vancomycin + other beta-lactam

30/102 (29.4 %)

24/96 (25 %)

0.80 (0.43–1.50)

0.49

No therapy

2/102 (2.0 %)

0/96

0.98 (0.96–1.01)

0.17

Other empiric therapy

10/102 (9.8 %)

11/96 (11.5 %)

1.19 (0.48–2.45)

0.71

  1. Abbreviation: CI confidence interval